Idea principal
In a randomized trial of 60 overweight and obese children, 3 months of omega-3 plus standard advice raised heart rate variability (RMSSD P = 0.017, SDNN P = 0.009, pNN50 P = 0.043) compared with standard advice alone. With only 30 children per group and a short follow-up, this is early evidence and says nothing about heart disease outcomes.
Study design
Ensayo aleatorizado
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Children with overweight or obesity are at risk of cardiovascular disease later, and heart rate variability (HRV) is a marker of heart and autonomic health. The authors tested whether omega-3 fatty acid supplements change HRV and blood fats in these children.
Población y método
Randomized interventional trial in 60 overweight and obese children: 30 received omega-3 supplements plus standard recommendations and 30 received standard recommendations only. A resting 10-minute Holter ECG was recorded at the start and after 3 months in both groups to compare HRV, and lipid profiles were also measured. The abstract does not give ages, the omega-3 dose, or how the children were randomized.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Compared with controls, the omega-3 group had significantly greater increases in RMSSD (P = 0.017), SDNN (P = 0.009) and pNN50 (P = 0.043), measures of beat-to-beat variability. The abstract does not give the size of the changes.
- 2Among blood fats, only two differed: triglycerides fell significantly (P = 0.006) and HDL cholesterol rose significantly (P = 0.005) in the omega-3 group relative to controls.
- 3The other lipid measures did not differ significantly between groups.
Límites e incertidumbre
- 1Small sample (30 per group) and a single 3-month period; the abstract does not say if effects last or if children's weight changed.
- 2The abstract gives p values but no effect sizes or confidence intervals, and does not say whether the control group received a placebo, so blinding and placebo effects are unclear.
- 3HRV and lipids are surrogate markers; the study cannot show fewer heart problems later, and the authors' phrase 'cardioprotective' goes beyond what was measured. This reading is based on the abstract only.
Relevancia práctica
Omega-3 supplements may nudge HRV and triglycerides in overweight children, but this small trial does not show they protect the heart. It does not replace diet, activity and weight guidance. Decisions about supplements for a child belong with a pediatrician.
Tus datos
Resting HRV from a chest strap or watch can be tracked, but children's values vary with age, sleep and recent activity, and a 10-minute Holter ECG is not the same as a wearable reading. If you track HRV, compare your own readings under the same conditions and over several weeks.
Cómo interpretar la evidencia
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Overweight and obese children are risky for developing chronic cardiovascular disorders. Heart rate variability is a valuable indicator of the cardiovascular health.
Aim
To outline the impact of supplementation of omega-3 on the variability of the heart rate.
Methods
A randomized interventional control study has been done on 60 overweight and obese children; 30 children were assigned to the interventional group who received omega-3 with the standard recommendations and 30 children were assigned to the control group who received the standard recommendations only. Resting 10 min Holter ECG was done at the start and after 3 months of omega-3 supplementation in both groups to observe and compare the difference in the heart rate variability. In addition, lipid profiles were investigated and compared.
Results
Difference in measures of the heart rate variability; RMSSD, SDNN, and pNN50 were increased significantly in cases compared to the controls (P value = 0.017, 0.009, and 0.043 respectively). Differences in measures of the lipid profiles differed only in triglycerides which decreased significantly in cases and HDL which increased significantly in the cases (P value = 0.006, 0.005 respectively).
Conclusion
Our results suggested that omega-3 supplementation might improve cardiovascular health in overweight and obese children.
Impact
This study discloses the importance of supplementation of omega-3 fatty acids as a cardioprotective dietary supplement. Omega-3 fatty acids can improve heart rate variability in overweight and obese children. Omega-3 fatty acids can also improve the lipid profiles in overweight and obese children.
Fuentes y atribución
Omega and heart rate variability in overweight and obese schoolchildren.
Ibrahim HAA, Sobhi R, Khaled Farouk N, Mohamed AbdelAziz F.
Pediatric research · 2025-02-19
DOI: 10.1038/s41390-025-03913-5 ↗PubMed · 39972155 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Short-term HRV was higher during slow breathing in 962 military men, injured or not
In 962 military men (median age 37.6 years), every short-term heart rate variability (HRV) measure was higher during slow breathing at six breaths a minute than during spontaneous breathing, injured or not; in fast resting breathers RMSSD rose from 15.57 to 21.89 ms. It was one session in a fixed order, so it shows an immediate effect, not lasting benefit.
European Journal of Applied Physiology
Cold-water immersion: no strength gain, briefly weaker jumps, soreness relief uncertain
Across 22 randomised trials (375 participants, mostly men), one cold-water immersion after exercise did not change maximal isometric strength (g 0.08, 95% CI −0.11 to 0.26) and was followed by weaker jumping straight afterwards (g −0.68), gone by 24–48 hours. Lower soreness and creatine kinase looked favourable but weakened in sensitivity checks, and certainty was low to very low.
PeerJ
Cold-water immersion after hard exercise: less soreness, better power, no strength gain
In a meta-analysis of 52 randomised trials, cold-water immersion after high-intensity exercise was followed 24 hours later by lower soreness (SMD −0.89), higher perceived recovery (0.66) and better muscular power (0.22), with no effect on strength. Participants could not be blinded, most were men, and many pooled results rest on few studies with high heterogeneity.
Sports Medicine
Acute:chronic workload ratio: no evidence it can reduce injury risk, authors argue
The authors argue there is no evidence for using the acute:chronic workload ratio (ACWR) in training-load management or to reduce injury risk: no study has properly estimated a causal effect, and the ratio is statistically inaccurate and ambiguous. This is a methodological critique, not a new data analysis, so it does not show that training load is unrelated to injury.
International Journal of Sports Physiology and Performance

